We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+4.43%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$617M
AUM Growth
-$413M
Cap. Flow
-$455M
Cap. Flow %
-73.77%
Top 10 Hldgs %
54.35%
Holding
5,864
New
1,647
Increased
1,144
Reduced
1,785
Closed
1,178

Sector Composition

Rank Sector Weight
1 Financials 1.97%
2 Technology 1.44%
3 Real Estate 1.39%
4 Energy 1.34%
5 Industrials 1.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFX
3826
DELISTED
BowFlex Inc.
BFX
$2K ﹤0.01%
100
-9,878
-99% -$173K
SIEN
3827
DELISTED
Sientra, Inc.
SIEN
$2K ﹤0.01%
26
-475
-95% -$24.7K
SUNW
3828
DELISTED
Sunworks, Inc.
SUNW
$2K ﹤0.01%
+80
New +$1.69K
GOL
3829
DELISTED
Gol Linhas Aéreas Inteligentes S.A. American Depositary Shares (Each representing Ten Preferred Shares)
GOL
$2K ﹤0.01%
2,093
-1,296
-38% -$2.21K
HALL
3830
DELISTED
Hallmark Financial Services, Inc.
HALL
$2K ﹤0.01%
19
-466
-96% -$57.6K
FRTX
3831
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$2K ﹤0.01%
+2
New +$2.61K
EDI
3832
DELISTED
Virtus Stone Harbor Emerging Markets Total Income Fund
EDI
$2K ﹤0.01%
+200
New +$2.41K
ACER
3833
DELISTED
Acer Therapeutics Inc
ACER
$2K ﹤0.01%
86
+69
+406% +$2.28K
FRBK
3834
DELISTED
Republic First Bancorp Inc
FRBK
$2K ﹤0.01%
375
-8,849
-96% -$36.4K
KDNY
3835
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$2K ﹤0.01%
+17
New +$2.31K
KBAL
3836
DELISTED
Kimball International
KBAL
$2K ﹤0.01%
200
-15,628
-99% -$173K
BIOC
3837
DELISTED
Biocept, Inc.
BIOC
0
EXD
3838
DELISTED
Eaton Vance TaxManaged Buy-Write Strategy Fund
EXD
$2K ﹤0.01%
122
-58
-32% -$724
FCRD
3839
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$2K ﹤0.01%
191
-674
-78% -$7.71K
RFP
3840
DELISTED
Resolute Forest Products Inc.
RFP
$2K ﹤0.01%
200
AHPI
3841
DELISTED
Allied Healthcare Products
AHPI
$2K ﹤0.01%
1,062
-1,548
-59% -$3.71K
ZVO
3842
DELISTED
Zovio Inc. Common Stock
ZVO
$2K ﹤0.01%
232
-24
-9% -$191
CCXI
3843
DELISTED
ChemoCentryx, Inc.
CCXI
$2K ﹤0.01%
+200
New +$1.42K
GBT
3844
DELISTED
Global Blood Therapeutics, Inc.
GBT
$2K ﹤0.01%
65
-2,265
-97% -$98.1K
USAK
3845
DELISTED
USA Truck Inc
USAK
$2K ﹤0.01%
100
-3,996
-98% -$75K
LFC
3846
DELISTED
China Life Insurance Company Ltd.
LFC
$2K ﹤0.01%
100
-896
-90% -$16K
ATHX
3847
DELISTED
Athersys, Inc. Common Stock
ATHX
$2K ﹤0.01%
86
-394
-82% -$10.4K
NEV
3848
DELISTED
NUVEEN ENHANCED MUNICIPAL VALUE FUND
NEV
$2K ﹤0.01%
100
-2,992
-97% -$45.9K
TSC
3849
DELISTED
TriState Capital Holdings, Inc.
TSC
$2K ﹤0.01%
139
-1,878
-93% -$24K
ANAT
3850
DELISTED
American National Group, Inc. Common Stock
ANAT
$2K ﹤0.01%
19
-305
-94% -$31.5K

Similar funds

Tower Research Capital (TRC)'s Q4 2015 Portfolio in Review

As of Q4 2015, Tower Research Capital (TRC) held 5,864 positions worth $617M, down 40% from $1.03B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Tower Research Capital (TRC) withdrew a net $455M in Q4 2015, closing 1,178 positions and reducing 1,785 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $28.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 2% of assets, down from 2.2% a quarter earlier, followed by Technology and Real Estate.

Against the trend, Tower Research Capital (TRC) opened a new position in ProShares Short S&P500 worth $5.21M.

  • Tower Research Capital (TRC)'s largest Q4 2015 buy was ProShares Short S&P500: 31,192 shares worth $5.21M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2015, an estimated $17.5M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $203M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 Growth ETF in Q4 2015, selling an estimated $28.6M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 54% of its $617M portfolio in Q4 2015.
  • Tower Research Capital (TRC) opened 1,647 new positions and closed 1,178 in Q4 2015.
  • Tower Research Capital (TRC)'s portfolio value fell 40% quarter-over-quarter to $617M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2015, filed 10 Feb 2016.